Cargando…
Role of Measurable Residual Disease in Older Adult Acute Myeloid Leukemia
There is overwhelming evidence indicating that the use of measurable residual disease (MRD) as a biomarker provides critical prognostic information and that MRD may have a role in directing postremission decisions. There are a variety of assays for MRD assessment, such as multiparameter flow cytomet...
Autores principales: | Li, Xueyao, Tong, Xiuzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258117/ https://www.ncbi.nlm.nih.gov/pubmed/37313310 http://dx.doi.org/10.2147/CIA.S409308 |
Ejemplares similares
-
Role of Minimal (Measurable) Residual Disease Assessment in Older Patients with Acute Myeloid Leukemia
por: Buccisano, Francesco, et al.
Publicado: (2018) -
Technical Advances in the Measurement of Residual Disease in Acute Myeloid Leukemia
por: Roloff, Gregory W., et al.
Publicado: (2017) -
Measurable Residual Disease in High-Risk Acute Myeloid Leukemia
por: Cluzeau, Thomas, et al.
Publicado: (2022) -
Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia
por: Aitken, Marisa J. L., et al.
Publicado: (2021) -
Measurable residual disease in chronic myeloid leukemia
por: Branford, Susan, et al.
Publicado: (2022)